CAS No.:3930-19-6
Name: Streptonigran
Details Introduction
TOXICITY DATA with REFERENCE:
1. |
mmo-sat 100 ng/plate |
PNASA6 Proceedings of the National Academy of Sciences of the United States of America. 79 (1982),7445. | ||
2. |
mmo-bcs 600 µg/L |
CMMUAO Chemical Mutagens. Principles and Methods for Their Detection 9 (1984),165. | ||
3. |
ipr-rat LD50:150 µg/kg |
FATOAO Farmakologiya i Toksikologiya (Moscow). 37 (1974),197. | ||
4. |
orl-mus LD50:2330 µg/kg |
ANTBAL Antibiotiki. 12 (1967),132. | ||
5. |
ipr-mus LD50:520 µg/kg |
FATOAO Farmakologiya i Toksikologiya (Moscow). 37 (1974),197. | ||
6. |
scu-mus LD50:1000 µg/kg |
COREAF Comptes Rendus Hebdomadaires des Seances de lAcademie des Sciences. 261 (1965),4911. | ||
7. |
ivn-mus LD50:500 µg/kg |
85ERAY Antibiotics: Origin, Nature, and Properties. 2 (1978),1359. | ||
8. |
orl-dog LD50:500 µg/kg |
ANTBAL Antibiotiki. 11 (1966),1090. | ||
9. |
ivn-rat LD50:600 µg/kg |
ANTBAL Antibiotiki. 12 (1967),132. |
Consensus Reports:
Reported in EPA TSCA Inventory.
SAFETY PROFILE:
A deadly poison by ingestion, intraperitoneal, subcutaneous, and intravenous routes. An experimental teratogen. Experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx.
Hazard Codes: T+
Risk Statements: 28
R28:Very toxic if swallowed.
Safety Statements: 53-28-36/37/39-45
S53:Avoid exposure - obtain special instructions before use.
S28:After contact with skin, wash immediately with plenty of soap-suds.
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection.
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
RIDADR: UN 3462 6.1/PG 1
WGK Germany: 3
RTECS: TJ7350000
F: 10-18
HazardClass: 6.1(a)
PackingGroup: II
Standards and Recommendations:
Analytical Methods:
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione